BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34385562)

  • 1. Hematopoietic upstream stimulating factor 1 deficiency is associated with increased atherosclerosis susceptibility in LDL receptor knockout mice.
    Hoekstra M; Ren B; Laurila PP; Hildebrand RB; Soronen J; Frodermann V; Li Z; Boon MR; Geerling JJ; Rensen PCN; Jauhiainen M; Van Eck M
    Sci Rep; 2021 Aug; 11(1):16419. PubMed ID: 34385562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.
    Nahon JE; Hoekstra M; van Hulst S; Manta C; Goerdt S; Geerling JJ; Géraud C; Van Eck M
    Atherosclerosis; 2019 Feb; 281():47-55. PubMed ID: 30658191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages.
    Ruuth M; Soronen J; Kaiharju E; Merikanto K; Perttilä J; Metso J; Lee-Rueckert M; Taskinen MR; Kovanen PT; Öörni K; Olkkonen VM; Jauhiainen MS; Laurila PP
    Lipids Health Dis; 2018 Dec; 17(1):285. PubMed ID: 30545366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human proteoglycan 4 lowers inflammation and atherosclerosis susceptibility in female low-density lipoprotein receptor knockout mice.
    Hoekstra M; Snip OSC; Janusz P; Bernabé Kleijn MNA; Truitt ER; Sullivan BD; Schmidt TA; Jay GD; Van Eck M
    J Physiol; 2024 May; 602(9):1939-1951. PubMed ID: 38606903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.
    Laurila PP; Soronen J; Kooijman S; Forsström S; Boon MR; Surakka I; Kaiharju E; Coomans CP; Van Den Berg SA; Autio A; Sarin AP; Kettunen J; Tikkanen E; Manninen T; Metso J; Silvennoinen R; Merikanto K; Ruuth M; Perttilä J; Mäkelä A; Isomi A; Tuomainen AM; Tikka A; Ramadan UA; Seppälä I; Lehtimäki T; Eriksson J; Havulinna A; Jula A; Karhunen PJ; Salomaa V; Perola M; Ehnholm C; Lee-Rueckert M; Van Eck M; Roivainen A; Taskinen MR; Peltonen L; Mervaala E; Jalanko A; Hohtola E; Olkkonen VM; Ripatti S; Kovanen PT; Rensen PC; Suomalainen A; Jauhiainen M
    Sci Transl Med; 2016 Jan; 8(323):323ra13. PubMed ID: 26819196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility.
    van der Sluis RJ; van den Aardweg T; Reuwer AQ; Twickler MT; Boutillon F; Van Eck M; Goffin V; Hoekstra M
    J Endocrinol; 2014 Sep; 222(3):341-50. PubMed ID: 25063756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
    van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
    PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
    Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
    Yu P; Qian AS; Chathely KM; Trigatti BL
    Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstream Transcription Factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque.
    Fan YM; Hernesniemi J; Oksala N; Levula M; Raitoharju E; Collings A; Hutri-Kähönen N; Juonala M; Marniemi J; Lyytikäinen LP; Seppälä I; Mennander A; Tarkka M; Kangas AJ; Soininen P; Salenius JP; Klopp N; Illig T; Laitinen T; Ala-Korpela M; Laaksonen R; Viikari J; Kähönen M; Raitakari OT; Lehtimäki T
    Sci Rep; 2014 Apr; 4():4650. PubMed ID: 24722012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.
    Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ
    Am J Pathol; 2004 Sep; 165(3):785-94. PubMed ID: 15331403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
    Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
    Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
    Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1995-2003. PubMed ID: 9351364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.